UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046824
Receipt number R000053366
Scientific Title A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancer
Date of disclosure of the study information 2022/02/10
Last modified on 2023/02/03 09:09:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancer

Acronym

A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancer

Scientific Title

A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancer

Scientific Title:Acronym

A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancer

Region

Japan


Condition

Condition

Patients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer according to the General Rules for the Study of Pancreatic Cancer 7th edition written by Japan Pancreas Society, who performed upfront surgery, and diagnosed as suspicious or Class III (difficult to differentiate), Class IV (suspicious of malignancy), or Class V (positive/malignant) by peritoneal washing cytology on laparotomy.

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical significance, especially the prognosis of patients with resected pancreatic cancer diagnosed as suspicious-positive, Class III and Class IV (suspicious for malignancy) by peritoneal washing cytology, compared to those diagnosed as Class V (positive/malignant) .

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overall survival

Key secondary outcomes

Progression-free survival, presence of recurrence, first recurrence form


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with resected pancreatic cancer diagnosed as suspicious-positive, Class III and Class IV (suspicious for malignancy) by peritoneal washing cytology

Key exclusion criteria

Patients who underwent neoadjuvant treatment
Patients who have not undergone peritoneal washing cytology
Patients with negative, Class I or II results on peritoneal washing cytology

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Tsutomu
Middle name
Last name Fujii

Organization

Faculty of Medicine, Academic Assembly, University of Toyama

Division name

Department of Surgery and Science

Zip code

930-0194

Address

2630 Sugitani, Toyama city, Toyama, Japan

TEL

076-434-7331

Email

fjt@med.u-toyama.ac.jp


Public contact

Name of contact person

1st name Kazuto
Middle name
Last name Shibuya

Organization

Faculty of Medicine, Academic Assembly, University of Toyama

Division name

Department of Surgery and Science

Zip code

930-0194

Address

2630 Sugitani, Toyama city, Toyama, Japan

TEL

076-434-7331

Homepage URL


Email

shibuyak@med.u-toyama.ac.jp


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center for Clinical Research, Toyama University Hospital

Address

2630 sugitani, Toyama city, Toyama, Japan

Tel

076-415-8857

Email

rinri@adm.u-toyama.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 01 Month 29 Day

Date of IRB

2022 Year 02 Month 07 Day

Anticipated trial start date

2022 Year 02 Month 10 Day

Last follow-up date

2022 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancer


Management information

Registered date

2022 Year 02 Month 03 Day

Last modified on

2023 Year 02 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053366